CTRI/2019/08/020548Not yet recruitingPhase 3
tility of Tc-99m Ubiquicidin scintigraphy in patients with pyrexia of unknown origin
Dr Sumeet Suresh Malapure0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients with PUO as defined by the DT Durrack and AC street criteria.
- •(including classic, nosocomial, immune deficient(neutropenic) and HIV related)
Exclusion Criteria
- •Following patients shall be excluded from the study
- •i.Pregnant and breast feeding women
- •ii.Children < 18yr old.
Investigators
Similar Trials
Unknown
Not Applicable
The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast CancerTumor AngiogenesisBreast CancerNCT01503697Tel-Aviv Sourasky Medical Center75
Completed
Not Applicable
Technetium-99m HMPAO granulocyte scintigraphy as a tool to measure inflammatory load in Ulcerative Colitis: a cross-sectional studyInflammatory Bowel Diseasehttps://toetsingonline.ccmo.nl/ccmomon.nsf/0/A1A4F7B322EF7BF6C12579EC003742B8?EditDocument10017969Ulcerative ColitisNL-OMON37564Academisch Medisch Centrum30
Active, not recruiting
Phase 1
Place de la scintigraphie au 99mTc-Leukoscan® dans la prise en charge diagnostique des suspicions d’endocardite infectieuse sur matérielsEUCTR2017-000162-30-FRHospices Civils de Lyon
Not yet recruiting
Phase 1
Diagnostic efficacy of 99mTc-FAPI SPECT/CTMalignant neoplasm.Malignant neoplasmC00-C96IRCT20210612051548N5Boushehr University of Medical Sciences15
Withdrawn
Phase 2
99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic PlaquesAtherosclerotic PlaqueCarotid AtherosclerosisNCT03630835Assistance Publique - Hôpitaux de Paris